Sfoglia per SSD
Isothiazole dioxide derivative 6n inhibits vascular smooth muscle cell proliferation and protein farnesylation
2005 N. Ferri, F. Clerici, K. Yokoyama, D. Pocar, A. Corsini
Isothiazoles. Part XV. A mild and efficient synthesis of new antiproliferative 5-sulfanylsubstituted 3-alkylaminoisothiazole 1,1-dioxides
2006 F. Clerici, A. Contini, A. Corsini, N. Ferri, S. Grzesiak, S. Pellegrino, A. Sala, K. Yokoyama
Isovalerylcarnitine regulates immune function and apoptosis of U937 myeloid leukemic cells
2004 F. Ferrara, M. Falchi, D. Mihali, G.M. Diana, L. Paraboni, A. Bertelli
Issue with models of integration : "The IMPROVE Study"
2007 E. Tremoli, D. Baldassarre, O. behalf of the IMPROVE Study Group
Italian familial defective apolipoprotein B patients share a unique haplotype with other Caucasian patients
2001 A.B. Cefalù, C.M. Barbagallo, E. Sesti, R. Caldarella, F. Polizzi, G. Marino, D. Noto, M. Rolleri, S. Travali, G. Scalisi, A. Notarbartolo, A. Corsini, S. Bertolini, M.R. Averna
Italian guidelines for the management of adult individuals with overweight and obesity and metabolic comorbidities that are resistant to behavioral treatment
2024 M. Chianelli, L. Busetto, R. Vettor, B. Annibale, A. Paoletta, E. Papini, A. Albanese, M. Carabotti, D. Casarotto, G. De Pergola, O.E. Disoteo, I. Grandone, G. Medea, E. Nisoli, M. Raffaelli, S. Schiff, F. Vignati, M. Cinquini, M. Gonzalez-Lorenzo, V.A. Fittipaldo, S. Minozzi, M. Monteforte, A.C. Tralongo, R. Novizio, A. Persichetti, I. Samperi, A. Scoppola, G. Borretta, M. Carruba, M.G. Carbonelli, M. De Luca, S. Frontoni, S.G. Corradini, F. Muratori, R. Attanasio
Italian Immunization Goals : a Political or Scientific Heated Debate?
2018 C. Scavone, M. Sessa, E. Clementi, F. Rossi, A. Capuano
Italy
2009 M. Marinovich, M. Della Seta, P. Preziosi, I. Marcello, R. Binetti
Italy's stem-cell challenge gaining momentum
2010 E. Cattaneo, E. Cerbai, S. Garagna
ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors
2015 A. Lombardi, S. Landonio, C. Magni, S. Cheli, C. Mazzali, M.U. Mondelli, G. Rizzardini, E. Clementi, F.S. Falvella
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis : A Focus on the Present and an Outlook on the Future
2020 J. Angelini, R. Talotta, R. Roncato, G. Fornasier, G. Barbiero, L. Dal Cin, S. Brancati, F. Scaglione
Japan: are statins still good for everybody?
2006 C.R. Sirtori, L. Calabresi
JNK as an innovative target to tackle rett syndrome
2017 A.M. Castaldo, L. Buccarello, C. Rumio, A.M. Villa, I. Meloni, A. Renieri, T. Borsello
JNK Contributes to Hif-1α Regulation in Hypoxic Neurons
2010 X. Antoniou, A. Sclip, C. Ploia, A. Colombo, G. Moroy, T. Borsello
JNK pathway as therapeutic target to prevent degeneration in the central nervous system
2006 M. Repici, T. Borsello
JNK plays a key role in tau hyperphosphorylation in Alzheimer's disease models
2011 C. Ploia, X. Antoniou, A. Sclip, V. Grande, D. Cardinetti, A. Colombo, N. Canu, L. Benussi, R. Ghidoni, G. Forloni, T. Borsello
JNK regulates APP cleavage and degradation in a model of Alzheimer's disease
2009 A. Colombo, A. Bastone, C. Ploia, A. Sclip, M. Salmona, G. Forloni, T. Borsello
The JNK signalling transduction pathway in the brain
2012 X. Antoniou, T. Borsello
JNK signalling: a possible target to prevent neurodegeneration
2007 T. Borsello, F. G.
JNK3 as a therapeutic target for neurodegenerative diseases
2011 X. Antoniou, M. Falconi, D. Di Marino, T. Borsello
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile